Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001437749-25-009696
Filing Date
2025-03-28
Accepted
2025-03-28 07:14:24
Documents
30
Period of Report
2025-05-15

Document Format Files

Seq Description Document Type Size
1 FORM DEF 14A dmtp20250321_def14a.htm   iXBRL DEF 14A 995350
6 board.jpg GRAPHIC 61007
7 c01.jpg GRAPHIC 1547
8 chart01.jpg GRAPHIC 50296
9 chart02.jpg GRAPHIC 24759
10 chart03.jpg GRAPHIC 60452
11 chart04.jpg GRAPHIC 78022
12 diamedicalogo.jpg GRAPHIC 6910
13 dmacp01.jpg GRAPHIC 186279
14 dmacp02.jpg GRAPHIC 213507
15 logolarge.jpg GRAPHIC 20286
16 logosm.jpg GRAPHIC 6569
17 parsonssig.jpg GRAPHIC 2678
18 sig01.jpg GRAPHIC 3105
19 sig02.jpg GRAPHIC 3446
20 sig03.jpg GRAPHIC 4244
  Complete submission text file 0001437749-25-009696.txt   3230485

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA dmac-20241231.xsd EX-101.SCH 4090
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dmac-20241231_def.xml EX-101.DEF 1750
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE dmac-20241231_lab.xml EX-101.LAB 1775
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dmac-20241231_pre.xml EX-101.PRE 714
32 EXTRACTED XBRL INSTANCE DOCUMENT dmtp20250321_def14a_htm.xml XML 6003
Mailing Address 301 CARLSON PARKWAY SUITE 210 MINNEAPOLIS MN 55305
Business Address 301 CARLSON PARKWAY SUITE 210 MINNEAPOLIS MN 55305 (763) 496-5454
DiaMedica Therapeutics Inc. (Filer) CIK: 0001401040 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36291 | Film No.: 25781460
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)